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Abstract
Brucellosis is a worldwide zoonosis that affects livestock and humans and is caused by closely related Brucella spp., which
are adapted to intracellular life within cells of a large variety of mammals. Brucella can be considered a furtive pathogen that
infects professional and non-professional phagocytes. In these cells Brucella survives in a replicative niche, which is
characterized for having a very low oxygen tension and being deprived from nutrients such as amino acids and vitamins.
Among these vitamins, we have focused on riboflavin (vitamin B2). Flavin metabolism has been barely implicated in
bacterial virulence. We have recently described that Brucella and other Rhizobiales bear an atypical riboflavin metabolic
pathway. In the present work we analyze the role of the flavin metabolism on Brucella virulence. Mutants on the two
lumazine synthases (LS) isoenzymes RibH1 and RibH2 and a double RibH mutant were generated. These mutants and
different complemented strains were tested for viability and virulence in cells and in mice. In this fashion we have
established that at least one LS must be present for B. abortus survival and that RibH2 and not RibH1 is essential for
intracellular survival due to its LS activity in vivo. In summary, we show that riboflavin biosynthesis is essential for Brucella
survival inside cells or in mice. These results highlight the potential use of flavin biosynthetic pathway enzymes as targets
for the chemotherapy of brucellosis.
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Introduction
Brucellosis is a worldwide zoonosis that affects livestock and
humans and is caused by closely related Brucella spp. which are
adapted to intracellular life within cells of a large variety of
mammals. The most pathogenic species for humans are B.
melitensis, B. suis and B. abortus whose preferred host are goats,
pigs and cattle respectively. Transmission to humans occurs
mainly through the consumption of contaminated unpasteurized
dairy products and through direct contact with infected animals.
An estimated of 500,000 human infections per year still occur
worldwide [1].
Brucella can be considered a furtive pathogen that infects
professional and non-professional phagocytes. No classical viru-
lence factors, such as exotoxins, cytolysins, capsules, fimbria,
plasmids, lysogenic phages, resistant forms, antigenic variation,
endotoxic lipopolysaccharide or apoptotic inducers have been
described in Brucella spp. so far [2]. Progress in understanding the
molecular pathogenesis of the disease, vaccine engineering and
postgenomic approaches aimed at the discovery of new pathways
used by this pathogen to modify the intracellular environment may
lead to new preventive interventions.
Once internalized, Brucella resides within a membrane-bound
compartment, the Brucella-containing vacuole (BCV), which
sequentially interacts and fuses with early endosomes, lysosomes
and further traffics to the endoplasmic reticulum (ER) to generate
an ER-derived replicative niche [3,4,5]. After 12–24 h after cell
entry Brucella extensively replicates without restricting basic
cellular functions or inducing obvious damage to cells [6]. The
replicative niche is characterized for having a very low oxygen
tension and being deprived in nutrients such as amino acids and
vitamins [2]. The true virulence factors of Brucella are a complex
array of molecular determinants that confer the pathogen the
metabolic ability to thrive in the harsh intracellular conditions
allowing it to invade, resist intracellular killing, build the repli-
cative niche and replicate.
Although riboflavin (vitamin B2) is the precursor of the essential
flavin coenzymes FMN and FAD which participate in a myriad of
biochemical reactions, flavin metabolism has been barely impli-
cated in bacterial virulence. Flavoenzymes are involved in dozens
of crucial cellular processes such as energy metabolism, RedOx
reactions, detoxification and biosynthesis [7]. For example, FMN
is required as an electron acceptor for dehydrogenases in the
respiratory chain, and its deficiency induces increased levels of
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9435Cytochrome bd, a terminal oxidase known to work in microaero-
philic conditions which is also present in Brucella [8]. Thus, it is
likely that flavin metabolism would be related to pathogenesis
since Brucella needs to survive to oxidative stress, microaerobic
conditions and nutrient starvation and flavoenzymes or flavins
themselves may be playing a key role in those processes.
The metabolic pathway of riboflavin in bacteria, plants and
fungi has been described in some detail [9,10]. Briefly, the
biosynthesis of one riboflavin molecule requires one molecule
of GTP and two molecules of ribulose-5-phosphate. The imidazole
ring of GTP is hydrolytically opened, yielding a 4,5-diaminopyr-
imidine that is converted to 5-amino-6-ribitylaminouracil by a
sequence of deamination, side chain reduction, and dephos-
phorylation. Condensation of 5-amino-6-ribitylaminouracil with
3,4-dihydroxy-2-butanone-4-phosphate obtained from ribulose-
5-phosphate affords 6,7-dimethyl-8-ribityllumazine (lumazine).
Dismutation of the lumazine derivative yields riboflavin and 5-
amino-6-ribitylaminouracil, which is recycled in the biosynthetic
pathway (see Figure S1). Animals incorporate riboflavin as a
micronutrient from their diet or throughout saprophyte bacteria to
synthesize riboflavin-derived cofactors flavin mononucleotide
(FMN) and flavin adenine dinucleotide (FAD).
We have recently described that Brucella and other Rhizobiales
bear an atypical riboflavin metabolic pathway [10,11]. The
enzyme 6,7-dimethyl-8-ribityllumazine synthase (lumazine syn-
thase, LS) catalyzes the penultimate step in the biosynthesis of
riboflavin (see Figure 1). A phylogenetic analysis on eubacterial,
fungal and plant LSs allowed us to classify them into two
categories: Type-I LSs (pentameric or icosahedral) and Type-II
LSs (decameric). Brucella codes both a Type-I and a Type-II LS
called RibH1 and RibH2 respectively. Both enzymes show low
catalytic activity in vitro, suggesting that natural selection operating
over the riboflavin pathway favored the evolution of catalysts with
low reaction rates. The rationale behind this is that the excess of
flavins in the intracellular pool in Brucella could act as a negative
factor when these bacteria are exposed to oxidative or nitrosative
stress [12].
In the present work we analyze the role of flavin metabolism on
B. abortus intracellular survival, focusing at its two LS isoenzymes.
Mutants on the ribH1, ribH2 genes and a double ribH mutant were
generated. These mutants and different complemented strains
were tested for viability on cells and mice. In this fashion we have
established that at least one LS must be present for B. abortus
viability and that RibH2 and not RibH1 is neccesary for Brucella
intracellular replication due to its LS activity in vivo. In summary,
we show that flavin biosynthesis is essential for Brucella survival
inside cells and mice.
Results
Brucella Needs at Least One ribH Gene to Survive
In order to determine the role of the LS genes, simple and
double mutants for the ribH genes were generated. The ribH1
(BAB1_0791) mutant was made by clean non-polar deletion
because this gene is believed to be located in an operon (rib
operon). On the other hand, ribH2 (BAB2_0545) is an isolated
ORF, thus the ribH2 mutant was generated by disrupting the ribH2
gene with an antibiotic resistance cassette (see Material and
Methods). Both simple mutants were obtained without any major
difficulty and were confirmed by Western Blot analysis (Figure 2A,
lanes 1–3). They are not auxotrophic for riboflavin and grow at
wild-type rates in both rich (TSB) and minimal media (Gerhardt-
Wilson) (data not shown). We then tried to obtain the double ribH
mutant by disrupting ribH2 in a ribH1 mutant genetic context. All
attempts were unsuccessful, suggesting that the double mutation
might be lethal. To overcome this difficulty we changed our
strategy and the ribH1 mutant was complemented with a plasmid
harboring ribH1 under a constitutive promoter before ribH2
mutagenesis (see materials and methods for details). In this way a
chromosomal double ribH mutant (ribH1-ribH2) was obtained but
at the expense of keeping a rescue copy of ribH1 in an expression
plasmid (Figure 2A, lanes 4 and 6). These results indicate that the
double mutant ribH1-ribH2 is not viable probably because it lacks a
complete flavin biosynthesis pathway and that both genes encode
LS activity but only one ribH gene would be sufficient for the
bacteria to survive.
RibH1 and RibH2 Have LS Enzymatic Activity In Vivo
Given the above described mutagenesis studies and the fact that
both RibH1 and RibH2 exhibit poor in vitro activity as LSs
[11,13], we decided to assess if they exhibit this enzymatic activity
in vivo. To address this issue we designed a plasmid swap
experiment assuming that the pribH1Km plasmid that is harbored
by the ribH1-ribH2 strain is essential for the growth in TSB
medium (poor in riboflavin) (Figure 2A). Thus we tested if the
pribH1Km plasmid could be cured in the presence of another
plasmid from the same incompatibility group harboring different
inserts but with an ampicillin resistance plasmid (pBBR4) (see
Figure 3A for details). Theoretically, only plasmids that encode
active LSs would be able to replace the original pribH1Km plasmid
Figure 1. Bacterial, plant and fungal simplified riboflavin
biosynthetic pathway. 5-amino-6-ribitylaminouracil (A) and 3,4-
dihydroxy-2-butanone-4-phosphate (B) are condensed to give 6,7-
dimethyl-8-ribityllumazine (lumazine) (C) by lumazine synthase (LS)
during the penultimate step of the riboflavin biosynthesis. Riboflavin
(D) is finally synthesized by riboflavin synthase (RS) which condensates
two molecules of lumazine to yield one molecule of riboflavin and
recycle one molecule of 5-amino-6-ribitylaminouracil into the pathway.
B. abortus has two LSs, RibH1 and RibH2 which are Type-I and Type-II
LSs respectively.
doi:10.1371/journal.pone.0009435.g001
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selective pressure for keeping LS enzymatic activity when bacteria
are grown in riboflavin poor media. Figure 3Bi shows that RibH1
and RibH2 share the same enzymatic activity since the ribH1 gene
could be exchanged with ribH2. RibH1 also could be replaced by
the heterologous and characterized LS from Saccharomyces cerevisiae
(LS_sce) [14] confirming that RibH1 and RibH2 are both active
LSs in vivo (Figure 3Bi). As expected, pribH1Km cannot be cured in
the presence of an empty plasmid or with pribH2_W22A
(Figure 3Bii). RibH2_W22A contains a single amino acid mutation
located in the active site of the endogenous RibH2. This mutant
lacks enzymatic activity but its stability and structure are unaltered
(unpublished results). Thus, these results confirm that Brucella
needs at least one active LS to survive in riboflavin poor media. In
agreement with this conclusion, the metabolic pressure to keep
RibH1 can be overcome when very high levels of riboflavin
(500 mM) are added to the media. Under these conditions, both
the empty plasmid and the ribH2_W22A construct were able to
replace RibH1 in the ribH1-ribH2 mutant strain (Figure 3Biii). The
same clones did not survive when plated in TSB-Amp media
without the addition of riboflavin (Figure S2). Overall, these
experiments demonstrate that the two ribH genes of B. abortus code
for LS isoenzymes.
RibH2 Activity Is Essential for B. abortus Intracellular
Replication
Once established that both RibH1 and RibH2 can function as
active LS in vivo, we decided to evaluate whether they play a role in
virulence. For this purpose, we analyzed the intracellular
replication of single and double RibH mutants in a macrophagic
cell line and the persistence of these mutants in mice.
In J774 cells the wild-type strain showed a classical infection
profile, with a marked decrease in viability between 0 and 4 h
post-infection (p.i.) (Figure 4). This reflects cell entry and death by
oxidative burst and fusion of the BCVs to lysosomes followed by a
recovery phase where replication takes place after approximately
12 h p.i. (Figure 4). The ribH1 strain showed a similar behavior to
that of the wild-type strain. In contrast, ribH2 showed a marked
decrease in CFU counts at all time-points, suggesting that RibH2
is an important factor for intracellular life style. Complementation
of ribH2 by ectopic expression of RibH2 in a plasmid recovers this
attenuated phenotype: this strain exhibited an increased survival at
early times (1 and 4 h p.i.) and a similar curve to that of the wild-
type strain at later times. These results are indicative that RibH2 is
more important in the intracellular phase than RibH1. In spite of
the fact that the double ribH mutant is unable to synthesize flavins,
its intracellular flavin pool content is enriched when it is grown in
the presence of 500 mM riboflavin (as analyzed by thin layer
chromatography, results not shown). In clear agreement, the
double ribH mutant exhibited an increased survival at early time
points, but is unable to replicate at later times p.i. (Figure 4). This
is indicative that flavin biosynthesis is essential for metabolic
adaptation to the replicative niche.
To further characterize the mechanisms by which RibH2 acts
in intracellular survival, we analyzed the biogenesis of ribH2 BCVs
in HeLa cells by scoring the recruitment kinetics of the late
endosome/lysosome glycoprotein LAMP-1 and the lysosomal
luminal hydrolase cathepsin D. As previously described, LAMP-1
is rapidly acquired and then gradually excluded from wild-type
BCVs [3]. Accordingly, at 24 h p.i. the wild-type BCVs were able
to promote the maturation of replicative organelles and prolifer-
ated in LAMP-1 negative compartments. In contrast, the ribH2
BCVs acquired this glycoprotein with similar kinetics but
40,3%65,0 of BCVs retained LAMP-1 at 24 h, suggesting that
this mutant fails to control vacuole maturation in HeLa cells
(Figure 5A, 5C). As for cathepsin D, the percentage of ribH2
positive BCVs vacuoles increased from 2 to 6 h p.i.. Additionally,
at 24 h p.i. almost 50% of the phagosomes were positive for
cathepsin D, whereas most of the wild-type BCVs excluded this
molecule at the time points analyzed (Figure 5B). These results are
consistent with bacterial survival at 4 and 48 h p.i. in HeLa cells as
assessed by CFU counting (Figure S3). However, the number of
ribH2 CFUs retrieved at 48 h p.i. indicates that although the ribH2
mutant is less efficient to promote the BCV maturation in
comparison to the wild-type strain, it is capable of further survival
and replication.
The ribH mutants were also tested in mice infection. In
agreement with cell experiments, ribH1 behaved exactly as the
wild-type strain (Figure 6A) showing the expected peak in CFU per
spleen count at 14 days p.i. corresponding to the acute phase.
Figure 2. Western blot analysis of the mutants and complemented strains. (A) Wild-type B. abortus expresses both RibH1 and RibH2 in
culture (lane 1). Mutant strains ribH1 and ribH2 present only one band corresponding to RibH2 and RibH1 respectively (lanes 2 and 3). Ectopic
expression of RibH1 in ribH1 and RibH2 in ribH2 is confirmed in lanes 4 and 5 which in fact show higher amounts of these proteins than the wild-type
strain. The chromosomal double ribH mutant only presents the RibH1 band corresponding to ribH1 expressed from the rescue plasmid (lane 6). (B)
Plasmid swap Western blots using anti-RibH1 antibodies. Lane 1 shows the positive control where pribH1Km was replaced by pribH1Amp. RibH1
could not be detected when pribH2 or pLS_sce were used to cure the pribH1Km plasmid (lanes 2 and 3). Lanes 4 and 6 evidence that RibH1
expression was maintained when the pBB4 (empty) or pribH2_W22A were used to replace pribH1Km, but in the presence of riboflavin RibH1 was
again not detected respectively (lanes 5 and 7).
doi:10.1371/journal.pone.0009435.g002
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days p.i. ribH1 had no differences compared to the wild-type
strain. In contrast, the ribH2 strain showed a significant
attenuation at all times tested with a spleen bacterial count 100-
fold lower compared to the wild-type at 10 days p.i. and an even
larger drop at 40 days p.i. (1000-fold, Figure 6B). The com-
plemented ribH2+ pribH2 strain evidenced a larger bacterial count
than the wild-type strain at 14 days p.i, demonstrating that RibH2
is required for survival in mice. The double mutant lacking both
ribH genes was completely cleared by infected mice by day 14 p.i.,
indicating again that the biosynthesis of flavins is essential for
survival (Figure 6B).
Discussion
It is very difficult to characterize the main activities that support
Brucella virulence by means of classical biochemical or microbio-
logical studies. The main reason for this difficulty is the fact that
Brucella behaves very differently in culture than inside cells or
animal hosts. For these reasons, several genomic or proteomic
approaches have been used to detect the genes that are important
for virulence and pathogenesis. In some of these studies, ribH2 has
been identified as a differentially expressed gene. Al Dahouk et al.
have detected that RibH2, among other proteins, is present in
higher concentrations in intramacrophagic Brucellae than in cul-
ture [15]. Also, Lamontagne et al. made a comparative protein
expression analysis between the attenuated S19 and the infectious
2308 Brucella strains where RibH2 was again identified to be
augmented in the virulent strain [16]. In fact, RibH2 was
originally characterized as a serological marker of active infection
of both human and bovine brucellosis, implying that this protein is
highly expressed during the infectious process [17]. Remarkably,
the LS function is encoded by two different genes in Brucella, with
ribH1 located within the rib operon in chromosome I, and ribH2
located in chromosome II (Table 1). Chromosome I is thought
to code mainly housekeeping functions and chromosome II is
regarded to harbor virulence-related functions that are differen-
tially expressed during adaptation to the replicative niche inside
cells [18]. Also, RibH2 has a very unusual regulatory element,
the RFN element, which is supposedly a riboswitch found by
Figure 3. Both RibH1 and RibH2 have LS activity in vivo. (A) A schematic draft of the plasmid swap experiment is depicted. Different pBBR4
(Amp
r) constructs were introduced by conjugation into the ribH1-ribH2+pribH1Km strain (X: ribH1, ribH2, LS_sce, ribH2_W22A or an empty plasmid).
Exconjugants were selected by Amp and Km resistance. Then, three independent clones from each conjugation were cultured separately in TSB with
Amp for more than 15 generations. One hundred Amp
r clones were then replicated in Amp and Km plates and the percentage of Amp
r/Km
s was
determined. In the case when empty pBBR4 or pribH2_W22A were used, riboflavin (Ribo) was added or not to the TSB and TSA to demonstrate that
the presence of the final metabolite of the pathway could lead to the complete loss of LS activity in the cells. (B) The replica plates showed that more
than 90% of the clones were Amp
r/Km
s after the plasmid swap experiment when ribH1, ribH2 or LS_sce inserts were tested (panel i). In the case of the
ribH2_W22A insert or the empty plasmid (panel ii) less than 5% Amp
r/Km
s clones were obtained. When riboflavin was added during the plasmid swap
experiment more than 90% of the clones tested were Amp
r/Km
s when pribH2_W22A or pBBR4 (empty) were used to replace pribH1Km (panel iii).
doi:10.1371/journal.pone.0009435.g003
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the protein by sensing the FMN concentration [20,21]. Thus, the
presence of this regulatory element added to the experimental
evidence shown in this and other works are indicative that RibH2
harbors an important role in Brucella virulence.
Although Brucella RibH1 and RibH2 share only 21% of protein
sequence identity, their monomers are structurally very similar,
with a very low root mean square deviation (R.M.S.D.) of 1.50 A ˚
when 128 C
a are aligned from a total of 157–158 C
a. We have
previously speculated that one plausible explanation for the im-
portant role of RibH2 in Brucella virulence is that this new type of
decameric LS could harbor a novel yet unknown function [22]. To
address this hypothesis we complemented the ribH2 attenuated
strain with different constructs (Figure 7). When ribH2 is comple-
mented with an active LS (endogenous RibH2 or the heterologous
LS from yeast), the bacteria not only recover their virulence but
also acquire an increased capacity to survive inside macrophages.
In clear contrast, the complementation with the point-mutated
RibH2_W22A does not recover the attenuated phenotype. Thus,
it is unlikely that RibH2 is exerting a function different than LS.
Although the expression of two very similar LSs with the same
function in Brucella is an intriguing observation, our working
hypothesis is that the two ribH genes may be differentially ex-
pressed during the Brucella infection cycle. Brucella would use
RibH1 for flavin biosynthesis during the extracellular phase and
RibH2 during intracellular growth. In any case, the role of RibH2
points out to the importance of the biosynthetic pathway of flavins
in virulence. We speculate that the LS activity could be a key point
for the regulation of this pathway. In order to corroborate this
hypothesis we are currently studying the regulation of ribH genes
under different conditions.
As clearly shown in Figure 3, the ribH1-ribH2 mutant is only
viable at very high concentrations of exogenous flavins. This result
supports previous bioinformatic analyses that indicate that Brucella
lacks riboflavin transport activities. We infected cells with the
ribH1-ribH2 strain previously grown at high levels of riboflavin
(Figure 4). Strikingly, these bacteria show an increased capacity to
survive inside macrophages within the first stages of infection
(supposedly because of their elevated intracellular flavin pool) but
then they show an exponential drop in intracellular CFU counts
until they are completely eliminated from the cells. This result may
indicate that during the infection there is a high demand for flavins
and without endogenous biosynthesis the internal pool is depleted
within a few hours. Flavins would be essential for Brucella lifestyle
inside the replicative niche where bacteria are isolated and need to
survive to starvation and microaerobic respiration. Because there
are no LS enzymes present in animals, Brucella LSs constitute very
interesting targets for chemotherapy. LS inhibitors could lead to
bacterial riboflavin auxotrophy or to attenuated bacterial virulence
without endangering the mammalian host.
Two recent discoveries involving flavins in virulence and
symbiosis in Rhizobiales have raised particular interest: Taga
et al. demonstrated that in the symbiont Sinorhizobium meliloti the last
step of biosynthesis of vitamin B12 is based on the fragmentation
of FMN through the flavin destructase BluB, and Swartz et al.
demonstrated that B. abortus contains a light-activated histidine
kinase that binds a flavin chromophore and undergoes photo-
chemistry indicative of cysteinyl-flavin adduct formation. This
latter protein (BA-LOV-HK) appears to function as a photore-
ceptor that is directly related to Brucella survival and replication
within macrophages [23,24]. Thus, the role of flavin metabolism
in Brucella pathogenesis is a question of biological relevance and
appears not to be limited to the genus Brucella. We have performed
bioinformatic and biochemical analyses in other bacteria [11,22].
Many plant symbionts like Rhizobium, Sinorhizobium, Mesorhizobium
and Bradyrhizobium spp. and some pathogens like Ochrobactrum
anthropi, Pseudomonas syringae pv. tomato and Roseobacter denitrificans also
present two ribH genes in their genomes exhibiting one Type-I and
one Type-II LS. They are located in the respective genomes in the
same fashion as in Brucella, meaning that ribH1 is coded within the
rib operon while ribH2 is located as an isolated ORF with the
regulatory RFN element upstream. A Type-I LS-ribH gene
duplication might have occurred in a bacterial ancestor where
one of these genes evolved to a Type-II LS, providing positive
fitness for symbiosis or pathogenesis. Vertical and horizontal gene
transfer could be responsible for the distribution of the ribH genes
through the different taxa where two different types of LS are
found.
Two mammal pathogens, Rhodococcus equi and Actinobacillus
pleuropneumoniae, become avirulent when their riboflavin operons
are disrupted [25,26], and therefore these mutants seem to be
good candidates for live attenuated vaccines [27,28]. For these
reasons the ribH1-ribH2 strain generated in this work could also be
a very good candidate for developing a Brucella vaccine because it
can not synthesize riboflavin and it is completely attenuated in
cells and in mice. This strain also lacks the serological marker
RibH2 which could eventually be used to discriminate between
vaccinated and infected animals [29,30]. In summary, in this work
we show that flavin biosynthesis is essential for Brucella survival
inside cells and that the LSs constitute attractive targets for
chemotherapy and vaccine design.
Materials and Methods
Bacterial Strains
All live Brucella strains have been manipulated in a BSL-3 facility
at UNSAM University. Bacterial strains, plasmids and oligonu-
cleotides used in this study are listed in Tables 2, 3 and 4. B. abortus
strains were grown in Tryptic Soy Broth (TSB, BD), Tryptic Soy
Agar (TSA, BD) or Gerhardt-Wilson minimal medium at 37uCo n
a rotary shaker (250 rpm) or stove for plates [31]. When necessary,
Figure 4. RibH2 is involved in survival and replication in
J774A.1 macrophages. Macrophages infected with wild-type B.
abortus, ribH1, ribH2, ribH1-ribH2 mutants and the ribH2 complemented
strain (ribH2+pribH2) were lysed and intracellular CFUs per ml quantified
at different times after inoculation. Data shown (mean 6 standard error
of the mean) are representative of three independent experiments
performed.
doi:10.1371/journal.pone.0009435.g004
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concentrations: kanamycin (Km), 50 mg/ml; gentamicin (Gm),
3 mg/ml); carbenicillin (Cb), 50 mg/ml, nalidixic acid (Nal), 5 mg/
ml; and ampicillin (Amp), 50 mg/ml. Escherichia coli strains were
grown at 37uC on a rotary shaker (250 rpm) in Luria-Bertani
broth. For E. coli strains antibiotics were used at the following
concentrations: Km, 50 mg/ml; Gm, 20 mg/ml; Amp, 100 mg/ml
and streptomycin (Str), 25 mg/ml.
Construction of the B. abortus Mutants
ribH1 mutant. For the construction of the ORF BAB1_0791
(ribH1) unmarked chromosomal mutant two PCR fragments were
generated from regions flanking this ORF. Oligonucleotides
ribH1_F1 and ribH1_R1 were used to amplify a 0.3 Kbp frag-
ment including codons 1–7 and oligonucleotides ribH1_F2 and
ribH1_R2 were used to amplify a 0.3 Kbp fragment includ-
ing 150–157 codons of ribH1. Both fragments (containing com-
plementary regions) were ligated by overlapping PCR using
oligonucleotides ribH1_F1 and ribH1_R2. The resulting fragment
containing the ribH1 deletion allele was cloned into pBluescript-
KSII (Stratagene) in which the Bacillus subtilis sacB gene encoding
levansucrase (that induces lethality upon exposure to 5% (w/v)
sucrose in the growth medium) had been cloned in the PstI site to
generate pBlueKSIIsacBDribH1. This plasmid was introduced in
B. abortus 2308 by electroporation. The first recombination event
(integration of the suicide vector in the chromosome) was selected
by Cb resistance and 10% (w/v) sucrose sensitivity in TSA plates.
Cells were grown overnight in TSB in the absence of antibiotic
selection to promote recombination. The second recombination
event (excision of the plasmid and generation of the mutant strain
by allelic exchange) was selected by Cb sensitivity and 10% (w/v)
sucrose resistance in TSA plates. Colonies were screened by PCR
using oligonucleotides ribH1_F1 and ribH1_R2 that amplify a
fragment of 0.6 Kbp in the mutant strain and a fragment of
1.2 Kbp in the wild-type strain. The mutant strain carrying an
unmarked deletion of ribH1 was called ribH1.
ribH2 mutant. A PCR product of 0.9 Kbp containing ORF
BAB2_0545 (ribH2) was amplified using oligonucleotides ribH2_F1
and ribH2_R1 and ligated to pGem-T-Easy vector (Promega) to
generate pGem-TribH2. The plasmid was linearized with EcoRV.
Linearized pGem-TribH2 was ligated to a 0.7 Kbp SmaI fragment
containing a acc(3)-I cassette to generate pGem-TribH2::acc(3)-I.
This plasmid was electroporated into B. abortus 2308 where it is
incapable of autonomous replication. Homologous recombination
Figure 5. RibH2 is required to control BCV maturation in HeLa cells. HeLa cells were infected with B. abortus wild-type (black bars) or ribH2
(white bars) strains expressing GFP and were labeled with (A) anti-cathepsin D or (B) anti-LAMP-1 antibodies at 2, 6 and 24 h p.i. (C) Representative
fluorescence microscopy images at 4 and 24 h p.i. labeled with anti-LAMP-1 antibodies. White arrows show BCVs in infected HeLa cells. For (A) and
(B) each determination is the average of two independent experiments. Values are expressed as mean 6 standard error of the mean.
doi:10.1371/journal.pone.0009435.g005
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sensitivity (50 mg/ml) in TSA plates. PCR and sequencing analyses
showed that the ribH2 wild-type gene was replaced by the
disrupted one. The mutant strain obtained was called ribH2.
ribH1-ribH2 mutant. A 1 Kbp PCR product containing
ribH1 gene was first cloned into pGem-T-Easy and then excised
and ligated to the EcoRI site of pBBR2 [32] to generate
pribH1Km. This plasmid was conjugated into the ribH1 strain by
biparental mating to generate ribH1+pribH1Km. Then pGem-
TribH2::acc(3)-I plasmid was electroporated into this strain and
homologous recombination events were selected as previously
described. PCR and sequencing analyses showed that the ribH2
wild-type gene was replaced by the disrupted one. The mutant
strain obtained was called ribH1-ribH2+pribH1Km.
Conjugation by biparental mating. E. coli S17-1 [33] donor
strain and B. abortus strains were cultured separately, cells were
harvested during the exponential phase and 1 ml of each culture
was pelleted and washed twice with TSB. Bacteria were then
centrifuged, resuspended in residual liquid, mixed and plated
together in a single spot in a TSA plate without antibiotics. Plates
were incubated at 37uC overnight, afterwards the mix was plated in
TSA-Nal plates to select Brucella and exconjugants were selected for
the appropriate plasmidic antibiotic resistance.
Construction of the Complemented ribH2 Strains
RibH1. A 1 Kbp PCR product containing the ribH1 gene was
first cloned into pGem-T-Easy and then excised and ligated to the
EcoRI site of pBBR4 [32] to generate pribH1 where ribH1 is under
the lac promoter. This plasmid was conjugated into the ribH2
strain by biparental mating to generate ribH1 + pribH1Amp.
RibH2. A 0.9 Kbp EcoRI fragment containing ribH2 gene
was excised from pGem-TribH2 and ligated to the EcoRI site of
pBBR4. The resulting plasmid, pribH2, was conjugated into the
ribH2 strain by biparental mating to generate ribH2 + pribH2.
LS_sce. ORF YOL143C was amplified using the oligonu-
cleotides LS_sce_F and LS_sce_R from S. cerevisiae genomic DNA.
The resulting 0.6 Kbp PCR fragment was purified and digested
with XhoI and XbaI and ligated into pBBR4 digested with the
same restriction enzymes. The resulting plasmid, pLS_sce, was
confirmed by sequencing and conjugated into ribH2 strain by
biparental mating to generate ribH2 + pLS_sce.
RibH2_W22A. The ribH2_W22A mutation was generated
using the oligonucleotides W22A_F and ribH2_R2 to amplify the
first part of the ribH2 ORF, then the PCR product was purified
and used as a ‘‘megaprimer’’ for a second amplification round
using the oligonucleotide ribH2_F2. The resultant PCR product
was purified, digested with BamHI and ligated to pBBR4 di-
gested with the same restriction enzyme. The resulting plasmid,
pribH2_W22A, was confirmed by sequencing and conjugated into
ribH2 strain by biparental mating to generate ribH2 + pLS_sce.
Plasmid swap. To demonstrate that RibH1 and RibH2 are
LSs in vivo, we developed a plasmid swap experiment based the
instability of two vectors from the same incompatibility group
harbored in the same bacterial population. To this end, a pBBR4
plasmid harboring different inserts (ribH1, ribH2, ribH2_W22A,
LS_sce or an empty plasmid) was introduced by biparental mating
conjugation into the ribH1-ribH2 + pribH1Km strain. We selected
the presence of both vectors with Amp and Km. Three inde-
pendent Amp
r/Km
r clones from each conjugation were cultured
for at least 15 generations in TSB added with Amp only, then
dilutions were plated in TSA-Amp plates. One hundred colonies
from these plates were replica plated in TSA with Amp or Km.
When necessary, riboflavin (500 mM) was added to the TSB or
TSA. The percentage of Amp
r/Km
s clones was calculated for
each case (n=100).
Bacterial infection assays. Monolayers of J774.A1 cells
were seeded in 24-well plates (10
5 cells per well) and inocu-
lated with RPMI 1640 supplemented with 5% fetal calf serum
(FCS) containing 5610
5 bacteria (MOI=5:1). In order to ensure
close contact between cells and bacteria, multiwell plates were
centrifuged at 400 g for 10 min After 30 min of incubation at
37uC in a 5% CO2 atmosphere, cells were gently washed with
Figure 6. RibH2 mutant is attenuated in BALB/c mice infection.
(A) BALB/c mice were infected with wild-type B. abortus (black bars),
ribH1 mutant (white bars) or (B) ribH2 mutant (white bars), comple-
mented ribH2 strain (grey bars) or double ribH mutant (ND). After 14, 30,
40 or 60 days p.i. animals were sacrificed and spleens removed and
processed for CFU counts as described in Materials and Methods. Values
are expressed as mean 6 standard deviation of the mean (N=4).
Student’s unpaired two-tailed T-test was performed testing against
wild-type strain in all cases. ND: not detected, asterisks indicate
differences from wild-type infection treatment at the corresponding
time: ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0009435.g006
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1 h in medium supplemented with Str (100 mg/ml) and Gm
(50 mg/ml) to kill remaining extracellular bacteria. Thereafter, the
antibiotic concentration was decreased to 20 mg/ml of Str and
10 mg/ml of Gm. At the indicated times p.i., the number of
intracellular viable bacteria was determined as follows: cells were
washed three times with PBS and treated for 5 min with 0.5 ml of
0.1% Triton X-100. Lysates were serially diluted and plated on
TSA plates with the appropriate antibiotic to determine colony
forming units per ml (CFU/ml). Each determination is the average
of two independent experiments. Values are expressed as mean 6
standard error of the mean.
HeLa cells were seeded in coverslips (10
5 cells per coverslip)
and inoculated with minimal essential medium (MEM; Gibco)
supplemented with 5% FCS and 2 mM glutamine containing
5610
7 CFU of bacteria (MOI=500:1). Multiwell plates were
centrifuged at 400 g for 10 min After 1 h of incubation at 37uCi n
a5 %C O 2 atmosphere, cells were gently washed with PBS
(pH 7.4) and then incubated for 1 h in medium supplemented
with 100 mg/ml of Str and 50 mg/ml of Gm to kill remaining
extracellular bacteria. Thereafter, the antibiotic concentration was
decreased to 20 mg/ml of Str and 10 mg/ml of Gm. At the
indicated times p.i. cells were washed and fixed for immunoflu-
orescence.
Immunofluorescence microscopy. HeLa cells were washed
five times with PBS to remove non-adherent bacteria and fixed for
15 min in 3% paraformaldehyde (pH 7.4) at 37uC and then
processed for immunofluorescence labeling. Briefly, coverslips were
washed three times with PBS,incubatedfor10 min with PBS added
with 250 mM NH4Cl in order to quench free aldehyde groups.
Coverslips were then incubated with primary antibodies in a PBS
10% horse serum 0.1% saponin solution for 20 min at room
temperature, washed in PBS containing 0.1% saponin and then
incubated with secondary antibodies in a PBS 10% horse serum
0.1% saponin solution. The coverslips were mounted onto glass
slides using Mowiol (Aldrich). Cells were observed on the micro-
scope using a 1006oil immersion objective. Projections were saved
in TIFF format and imported to ADOBE PHOTOSHOP CS
where images were merged using RGB format. To determine the
percentages of bacteria that co-localized with the studied intra-
cellular markers a minimum of 100 intracellular bacteria (revealed
by indirect immunofluorescence) were counted. The assays were
performed in duplicate.
Antibodies and reagents. For immunofluorescence, the
primary antibodies used were mouse anti-human LAMP-1
H4A3 (Developmental Studies Hybridoma Bank, Department of
Biological Sciences, University of Iowa) or rabbit anti-human
cathepsin D (Dako). The secondary antibodies used were goat
anti-mouse or goat anti-rabbit Alexa Fluor 568 (Molecular Probes,
Invitrogen Co.). For DNA staining, Hoechst dye at 2 mg/ml
(final concentration) was used. For Western Blots, the primary
antibodies used were monoclonal anti-RibH2 and polyclonal anti-
RibH1 mice serum (both generated in our laboratory). The
secondary antibody used was goat anti-mouse IgG (Fc Specific)
Peroxidase Conjugate (Sigma).
Western blots. Bacteria were grown overnight with the
proper antibiotics and extra added riboflavin when necessary. The
same amount of protein was loaded into each lane in the gels.
Chemiluminiscent ECL Plus Western Blotting Detection System
(Amersham Biosciences), Storm Image and Detection system
(Molecular Dynamics) and Immobilon-NC Transfer Membranes
(Millipore) were used for the process.
Table 1. Comparison between RibH1 and RibH2 from B. abortus.
RibH1 RibH2 Reference
Monomer Lenght (residues) 157 158 [22,34]
Classification Type-I LS Type-II LS [11,22]
Quaternary arrangement Pentamer Decamer [11,22,35]
LS in vitro k cat (s-1) 0.005 s-1 (very low) 0.006 s-1 (very low) [11]
Chromosome location Chromosome I Chromosome II [11]
Part of the Rib operon Yes No [11]
Predicted regulatory element - RFN [11]
Involved in host immune response No Yes [17]
Involved in virulence No Yes This work
doi:10.1371/journal.pone.0009435.t001
Figure 7. LS enzymatic activity of RibH2 is essential for Brucella
survival. Wild-type B. abortus (black bar), ribH2 mutant (white bar) and
complemented ribH2 strains (grey bars) with pBBR4 plasmid harboring
different inserts (ribH1, ribH2, LS_sce, ribH2_W22A) were tested for
survival at 4 h p.i. in J774A.1 macrophages. Data shown (mean 6
standard error of the mean) are representative of three independent
experiments performed.
doi:10.1371/journal.pone.0009435.g007
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Strain Name Characteristics Source or reference
B. abortus strains 2308 wild-type, smooth, virulent, Nal
r Laboratory stock
2308 pGFP 2308, containing plasmid pGFP, Km
r This work
ribH1 2308, unmarked deletion of ribH1 This work
ribH1+pribH1 ribH1, containing plasmid pribH1, Amp
r This work
ribH2 2308, Gm
r, insertion of acc(3)-I cassette in ribH2 This work
ribH2 pGFP ribH2, containing plasmid pGFP, Km
r This work
ribH2+pribH2 ribH2, containing plasmid pribH2, Amp
r This work
ribH1-ribH2+pribH1Km ribH1, ribH2, containing plasmid pribH1Km, Km
r This work
ribH1-ribH2 ribH1, ribH2 This work
E. coli strains S17-1 recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 [33]
doi:10.1371/journal.pone.0009435.t002
Table 3. Plasmids used in this study.
Name Characteristics Source of reference
pBBR4 pBBR1MCS-4 Broad-host-range cloning vector, Amp
r [32]
pBBR2 pBBR1MCS-2 Broad-host-range cloning vector, Km
r [32]
pGemTribH2 0.9 Kbp EcoRI fragment containing ribH2 gene, cloned into pGemT-Easy vector, Amp
r This work
pribH1Amp 1 Kbp EcoRI fragment containing ribH1, cloned into pBBR1MCS-4 This work
pribH1Km 1 Kbp EcoRI fragment containing ribH1, cloned into pBBR1MCS-2 This work
pribH2 0.9 Kbp EcoRI fragment containing ribH2 gene, cloned into pBBR1MCS-4 This work
pribH2_W22A point mutant W22A ribH2 gene, cloned into pBBR1MCS-4 This work
pLS_sce RIB4 gene from Sacharomyces cerevisiae, cloned into pBBR1MCS-4 This work
pGFP gfp-mut3 cloned into pBBR1MCS-2 This work
pBluescript-KSII Commercial plasmid Stratagene
pGem-T-Easy Commercial plasmid Promega
pBlueKSIIsacBDribH1 DribH1 deletion allele and sacB from B. subtilis, cloned into pBluescript-KSII This work
pGem-TribH2::acc(3)-1 pGem-TribH2::acc(3)-I This work
doi:10.1371/journal.pone.0009435.t003
Table 4. Oligonucleotides used in this study.
Name Sequence
a Restriction Enzyme
ribH1_F1 CGGGATCCGCGCCTTTCATCGCGCAGAA BamHI
ribH1_R1 TCCAGACTGCTACGTATCGCCTTGGACATGAGAAACTCCAT -
ribH1_F2 GCGATACGTAGCAGTCTGGACGCAAAAAATTCGGAGCCTGA -
ribH1_R2 GGACTAGTCGCGACAGCGGCCAGTCTTC SpeI
ribH2_F1 GGAGAATGCGTGATAAATTCAA -
ribH2_R1 TCAGACAAGCGCGGCGAT -
ribH2_F2 TTAAGGATCCATGGCTAGCAACCAAAGC BamHI
ribH2_R2 ATTAGGATCCGCTAGCTCAGACAAGCG BamHI
LS_sce_F ATTACTCGAGATGCATCACCATCACCATCACGCAGTTAAAGGATTAGGCAAAC XhoI
LS_sce_R CGATTCTAGATCAAAAAGCATTTTTACCGAAC XbaI
W22A_F ATTCAGGCCCGCGCCCACGCCGACATC -
aRestriction endonuclease cleavage sites are underlined.
doi:10.1371/journal.pone.0009435.t004
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were inoculated intraperitoneally with 5610
5 CFU of the indi-
cated strains. At 14, 30, 40 or 60 days p.i. mice were sacrificed and
spleens were removed and homogenized in 2 ml of PBS. Tissue
homogenates were serially diluted and plated on TSA plates with
the appropriate antibiotics to determine colony forming units per
spleen (CFU/spleen). Values are expressed as mean 6 standard
errors of the mean (N=4).
All research involving animals has been conducted according to
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and all experimental protocols have been
approved by the Institutional Animal Care and Use Committee
(IACUC) of Leloir Institute.
Statistical analysis. Data are presented as mean 6 standard
error of the mean. Significance was reported using Student’s
unpaired two-tailed T-test (Prism, GraphPad Software). p-values,
0.05 were considered statistically relevant.
Supporting Information
Figure S1 Plants, fungi, and microorganisms share a common
flavin biosynthetic pathway. Animals take riboflavin as a vitamin
in their diets to synthesize FMN and FAD cofactors (by RK and
FS respectively).
Found at: doi:10.1371/journal.pone.0009435.s001 (2.12 MB EPS)
Figure S2 Amp
r/Km
s clones carrying empty pBBR4 or
pribH2_W22A derived from the plasmid swap experiment were
plated in TSB-Amp plates without the addition of riboflavin.
Control replica plates in TSB-Km plates with riboflavin added are
also shown.
Found at: doi:10.1371/journal.pone.0009435.s002 (1.32 MB TIF)
Figure S3 HeLa cells infected with wild-type B. abortus (black)
and ribH2 mutant (red) were lysed and intracellular CFUs per ml
quantified at different times after inoculation. Data shown (mean
6 standard error of the mean) are representative of three
independent experiments performed.
Found at: doi:10.1371/journal.pone.0009435.s003 (2.02 MB TIF)
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